[Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 16123869)

Published in Rofo on September 01, 2005

Authors

H Strunk1, J Bucerius, U Jaeger, A Joe, S Flacke, M Reinhardt, N Hortling, H Palmedo

Author Affiliations

1: Radiologische Universitätsklinik Bonn, Bonn. strunk@uni-bonn.de

Articles by these authors

bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell (1989) 6.66

Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J (1988) 3.77

Computer-enhanced "robotic" cardiac surgery: experience in 148 patients. J Thorac Cardiovasc Surg (2001) 2.40

Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 2.07

[Diagnosis of acute pulmonary embolism]. Dtsch Med Wochenschr (1998) 2.00

Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology (1999) 1.98

Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma. Cancer Res (2001) 1.98

Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses (1995) 1.92

Alternative end-joining in follicular lymphomas' t(14;18) translocation. Leukemia (2002) 1.71

Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases. Ann Oncol (2007) 1.67

JlpA, a novel surface-exposed lipoprotein specific to Campylobacter jejuni, mediates adherence to host epithelial cells. Mol Microbiol (2001) 1.63

[CT coronary angiography in patients with atrial fibrillation]. Rofo (2005) 1.42

Improved automated leucocyte counting and differential in newborns achieved by the haematology analyser CELL-DYN 3500. Clin Lab Haematol (1995) 1.40

[Erroneous diagnosis of liver metastasis as benign tumor in the contrast media aided "Low-MI-Real-Time" sonography with SonoVue]. Rofo (2005) 1.39

Novel CBF beta-MYH11 fusion transcripts and alternative splicing in acute myeloid leukemia with inversion of chromosome 16. Blood (1995) 1.38

MRI findings in Hirayama's disease: flexion-induced cervical myelopathy or intrinsic motor neuron disease? J Neurol (1999) 1.36

2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer (2001) 1.30

High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Haemost (2009) 1.28

Diffusion tensor pyramidal tractography in patients with anterior choroidal artery infarcts. AJNR Am J Neuroradiol (2007) 1.22

Sequence determination of the 3' end of mouse mammary tumor virus RNA. Mol Biol Rep (1981) 1.21

FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up. Eur J Nucl Med Mol Imaging (2005) 1.21

Oxygenation strategy and neurologic damage after deep hypothermic circulatory arrest. II. hypoxic versus free radical injury. J Thorac Cardiovasc Surg (1999) 1.18

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma. J Clin Oncol (1998) 1.15

Detectability and detection rate of acute cerebral hemisphere infarcts on CT and diffusion-weighted MRI. Neuroradiology (2000) 1.14

Chemoimmunotherapy with GA101 plus chlorambucil in patients with chronic lymphocytic leukemia and comorbidity: results of the CLL11 (BO21004) safety run-in. Leukemia (2012) 1.13

Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology (2000) 1.10

The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. Proc Natl Acad Sci U S A (2000) 1.09

Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose. Eur Urol (1999) 1.09

Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography. Endoscopy (2002) 1.07

FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporos Int (2002) 1.05

Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia (2002) 1.03

Detection of thrombosis in the portal venous system: comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography. Radiology (2000) 1.03

Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology (2001) 1.02

[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia (1996) 1.01

Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography. Anticancer Res (2005) 1.01

Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia. Ann Hematol (1996) 0.98

Diffusion- and perfusion-weighted magnetic resonance imaging in deep cerebral venous thrombosis. Stroke (1999) 0.98

[Indications for nuclear medicine therapy in advanced prostate carcinoma]. Urologe A (1998) 0.98

18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol (2006) 0.97

Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL). Leukemia (2004) 0.96

Prevalence of overweight and obesity among school children in Jena (Germany). Int J Obes Relat Metab Disord (1999) 0.96

Cystatin C-based calculation of glomerular filtration rate in kidney transplant recipients. Kidney Int (2006) 0.96

Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome. Leukemia (2004) 0.95

FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur J Nucl Med (2001) 0.94

[Scintigraphically "hot" thyroid nodules mainly go hand in hand with a normal TSH]. Nuklearmedizin (2011) 0.94

[Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors]. Urologe A (1998) 0.94

Redifferentiation therapy-induced radioiodine uptake in thyroid cancer. J Nucl Med (1998) 0.93

In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells. Proc Natl Acad Sci U S A (1999) 0.93

[1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence]. Rofo (2002) 0.92

Absence of foamy virus DNA in Graves' disease. AIDS Res Hum Retroviruses (1994) 0.91

FDG-PET in monitoring therapy of breast cancer. Eur J Nucl Med Mol Imaging (2004) 0.91

High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum (1994) 0.91

In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration. Amino Acids (2002) 0.91

Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment. Anticancer Res (1997) 0.91

Cerebral perfusion during transient global amnesia: findings with HMPAO SPECT. J Nucl Med (1998) 0.90

Three-dimensional time-of-flight MR angiography at 3 T compared to digital subtraction angiography in the follow-up of ruptured and coiled intracranial aneurysms: a prospective study. Neuroradiology (2008) 0.90

Studies on the quality of breast milk during 23 months of lactation in a rural community of the Ivory Coast. Am J Clin Nutr (1979) 0.90

Wideband harmonic imaging: a novel contrast ultrasound imaging technique. Eur Radiol (1999) 0.90

Comparison of 18FDG-PET with 131iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid (1997) 0.88

Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand (1998) 0.88

Local intra-arterial thrombolysis in the carotid territory: does recanalization depend on the thromboembolus type? Neuroradiology (2002) 0.88

Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12. Eur J Clin Invest (2009) 0.88

[Diagnostic imaging of vascular leiomyosarcomas]. Rofo (2004) 0.87

Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells. Br J Haematol (2000) 0.87

Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study. Blood (1997) 0.87

Analysing the response in R2* relaxation rate of intracranial tumours to hyperoxic and hypercapnic respiratory challenges: initial results. Eur Radiol (2010) 0.86

AAV for pain: steps towards clinical translation. Gene Ther (2009) 0.86

Post-transplant acute myeloid leukemia (PT-AML). Leukemia (1999) 0.86

Unilateral iodine-131 uptake in the lactating breast. J Nucl Med (1995) 0.86

Reactor-produced radioisotopes from ORNL for bone pain palliation. Appl Radiat Isot (1998) 0.86

Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas. Clin Cancer Res (2000) 0.86

Selective internal radiation therapy (SIRT) in primary or secondary liver cancer. Methods (2011) 0.85

Postischemic hyperthermia exacerbates neurologic injury after deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg (1998) 0.85

Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma. Anticancer Res (1997) 0.85

Requirement for renal replacement therapy in patients undergoing cardiac surgery. Thorac Cardiovasc Surg (2004) 0.85

Acoustic behaviour of current ultrasound contrast agents. Ultrasonics (2000) 0.84

Polarized transport of the polymeric immunoglobulin receptor in transfected rabbit mammary epithelial cells. J Cell Biol (1990) 0.84

Cephalosporin-induced cholestatic jaundice. Lancet (1982) 0.84

[Technical limits of PET/CT with 18FDG in prostate cancer]. Aktuelle Urol (2006) 0.83

Testicular function after radioiodine therapy for thyroid carcinoma. Eur J Nucl Med (2000) 0.83

Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML. Ann Hematol (1998) 0.83

Cryptosporidia--who is at risk? Schweiz Med Wochenschr (1995) 0.83

[Differentiated short- and long-term effects of a "Training of Emotional Intelligence" and of the "Integrated Psychologic Therapy Program" for schizophrenic patients?]. Fortschr Neurol Psychiatr (2001) 0.83

"High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma. J Nucl Med (1996) 0.83

Beta-trace protein-based equations for calculation of GFR in renal transplant recipients. Am J Transplant (2008) 0.82

[MRI diagnosis in longitudinal stress fractures: differential diagnosis of Ewing sarcoma]. Rofo (1999) 0.82

Oxygenation strategy and neurologic damage after deep hypothermic circulatory arrest. I. Gaseous microemboli. J Thorac Cardiovasc Surg (1999) 0.82

In vivo molecular imaging of apoptosis and necrosis in atherosclerotic plaques using microSPECT-CT and microPET-CT imaging. Mol Imaging Biol (2014) 0.82

Expression of the nerve growth factor receptor c-TRK in human myeloid leukaemia cells. Br J Haematol (1996) 0.82

Nasal immunisation with Salmonella typhimurium producing rotavirus VP2 and VP6 antigens stimulates specific antibody response in serum and milk but fails to protect offspring. Vaccine (2001) 0.82

Metastasis to pituitary adenoma: case report and review of the literature. Cent Eur Neurosurg (2009) 0.82

Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation. Eur J Med Res (2009) 0.82

[MR whole-spine recording: computer-assisted simulation of the conventional x-ray technic]. Rofo (1999) 0.82

Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy. J Nucl Med (1992) 0.82

High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study. Am J Clin Pathol (2000) 0.82

[Submillimeter 3D coronary MR angiography with real-time navigator correction in 107 patients with suspected coronary artery disease]. Rofo (2002) 0.81

Contributions to the epidemiology of liver cirrhosis and chronic hepatitis. Dtsch Z Verdau Stoffwechselkr (1982) 0.81